These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX. Yuan Y, Zhang W, Yan R, Liao Y, Zhao L, Ruan C, Du X, Dai K. Circ Res; 2009 Dec 04; 105(12):1177-85. PubMed ID: 19875727 [Abstract] [Full Text] [Related]
5. Moderate-intensity exercise suppresses platelet activation and polymorphonuclear leukocyte interaction with surface-adherent platelets under shear flow in men. Wang JS, Liao CH. Thromb Haemost; 2004 Mar 04; 91(3):587-94. PubMed ID: 14983236 [Abstract] [Full Text] [Related]
7. Paradoxical Effect of Nonphysiological Shear Stress on Platelets and von Willebrand Factor. Chen Z, Mondal NK, Ding J, Koenig SC, Slaughter MS, Wu ZJ. Artif Organs; 2016 Jul 04; 40(7):659-68. PubMed ID: 26582038 [Abstract] [Full Text] [Related]
8. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera. Michiels JJ, Berneman Z, Schroyens W, Finazzi G, Budde U, van Vliet HH. Semin Thromb Hemost; 2006 Sep 04; 32(6):589-604. PubMed ID: 16977569 [Abstract] [Full Text] [Related]
9. A G-quartet oligonucleotide blocks glycoprotein Ib-mediated platelet adhesion and aggregation under flow conditions. Zhou Z, Bernardo A, Zhu Q, Guan Y, Sun W, Lopez JA, Jing N, Dong JF. Thromb Haemost; 2009 Sep 04; 102(3):529-37. PubMed ID: 19718474 [Abstract] [Full Text] [Related]
10. Simulation of platelet adhesion and aggregation regulated by fibrinogen and von Willebrand factor. Mori D, Yano K, Tsubota K, Ishikawa T, Wada S, Yamaguchi T. Thromb Haemost; 2008 Jan 04; 99(1):108-15. PubMed ID: 18217141 [Abstract] [Full Text] [Related]
12. Hypergravity results in human platelet hyperactivity. Li S, Shi Q, Wang Z, Yan R, Cheng H, Dai K. J Physiol Biochem; 2009 Jun 04; 65(2):147-56. PubMed ID: 19886393 [Abstract] [Full Text] [Related]
13. Anti-glycoprotein VI treatment severely compromises hemostasis in mice with reduced alpha2beta1 levels or concomitant aspirin therapy. Grüner S, Prostredna M, Aktas B, Moers A, Schulte V, Krieg T, Offermanns S, Eckes B, Nieswandt B. Circulation; 2004 Nov 02; 110(18):2946-51. PubMed ID: 15505105 [Abstract] [Full Text] [Related]
14. Increased platelet deposition on extracellular matrix under flow conditions in patients with antiphospholipid syndrome who experience thrombotic events. Levy Y, Shenkman B, Tamarin I, Pauzner R, Shoenfeld Y, Langevitz P, Savion N, Varon D. Arthritis Rheum; 2005 Dec 02; 52(12):4011-7. PubMed ID: 16320349 [Abstract] [Full Text] [Related]
15. Device-induced platelet dysfunction in mechanically assisted circulation increases the risks of thrombosis and bleeding. Chen Z, Zhang J, Kareem K, Tran D, Conway RG, Arias K, Griffith BP, Wu ZJ. Artif Organs; 2019 Aug 02; 43(8):745-755. PubMed ID: 30805954 [Abstract] [Full Text] [Related]
16. The role of von Willebrand factor in platelet function. de Groot PG. Semin Thromb Hemost; 2002 Apr 02; 28(2):133-8. PubMed ID: 11992236 [Abstract] [Full Text] [Related]
20. Decreased platelet level in peripheral blood of mice by microgravity. Fuse A, Aoki Y, Sato T, Sunohara M, Takeoka H. Biol Sci Space; 2002 Nov 02; 16(3):159-60. PubMed ID: 12695601 [Abstract] [Full Text] [Related] Page: [Next] [New Search]